Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amn Healthcare Services (AMN) EBIT (2016 - 2025)

Amn Healthcare Services' EBIT history spans 16 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, EBIT rose 104.01% year-over-year to $8.1 million; the TTM value through Dec 2025 reached -$55.5 million, up 45.97%, while the annual FY2025 figure was -$55.5 million, 45.97% up from the prior year.
  • EBIT reached $8.1 million in Q4 2025 per AMN's latest filing, down from $47.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $207.9 million in Q1 2022 to a low of -$202.6 million in Q4 2024.
  • Average EBIT over 5 years is $65.3 million, with a median of $89.3 million recorded in 2023.
  • Peak YoY movement for EBIT: surged 488.27% in 2021, then crashed 692.78% in 2024.
  • A 5-year view of EBIT shows it stood at $168.6 million in 2021, then fell by 29.26% to $119.3 million in 2022, then plummeted by 71.35% to $34.2 million in 2023, then plummeted by 692.78% to -$202.6 million in 2024, then surged by 104.01% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for AMN's EBIT are $8.1 million (Q4 2025), $47.6 million (Q3 2025), and -$123.7 million (Q2 2025).